Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Incannex Healthcare Limited - American Depositary Shares (NQ: IXHL )

2.205 +0.090 (+4.26%)
Streaming Delayed Price Updated: 3:57 PM EDT, Mar 31, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 7,963
Open 2.110
Bid (Size) 2.010 (1)
Ask (Size) 2.400 (5)
Prev. Close 2.115
Today's Range 2.100 - 2.416
52wk Range 1.770 - 9.670
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Cannabis Category Performances Ranged From +8.6% To -7.0% This Week
The 5 categories in the cannabis sector perform quite differently from each other and this week was a prime example. 
Via Talk Markets
Psyched: 22 States With Reform Bills, Ketamine Therapy Services Today, Oscars On Shrooms & More
Psychedelics Reform Update: 22 States Where Proposals Are Being Discussed & Local Moves Considered 
Via Benzinga

Performance

YTD
-27.59%
-27.59%
1 Month
-11.80%
-11.80%
3 Month
-21.25%
-21.25%
6 Month
-49.22%
-49.22%
1 Year
-75.93%
-75.93%

More News

Read More
Incannex Healthcare Prepares To Launch Psychedelics Clinics Via New Subsidiary
Via Benzinga
Psychedelic Trials Update: Treating Meth Addiction, Fibromyalgia & General Anxiety Disorder
Via Benzinga
Why Incannex Healthcare Shares Are Gaining Today
Via Benzinga
Incannex Healthcare Has World's Largest Pipeline Of Psychedelic Products
Via Talk Markets
Why American Public Education Shares Are Trading Lower By Around 49%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
All 5 Cannabis Categories Down Last Week; Only 1 Is UP YTD
Via Talk Markets
Psyched: 9 US Reform Bills, Ayahuasca 'A Release' For Prince Harry, At-Home Therapy & More
Via Benzinga
Here Are The Year's Highest Priced Psychedelics Stocks In US Markets
Via Benzinga
Incannex to work with Catalent to produce psilocybin for clinical and potentially commercial use
Via News Direct
Incannex to work with Catalent to produce psilocybin for clinical and potentially commercial use
Via TheNewswire.com
Incannex Engages Catalent For Development And Manufacture Of Psilocybin Drug For Clinical Trials
Via Benzinga
Incannex Healthcare kicks off Phase 2 rheumatoid arthritis trial
Via TheNewswire.com
Incannex Healthcare kicks off Phase 2 rheumatoid arthritis trial
Via News Direct
Incannex Starts Phase 2 Clinical Trial Of CBD-Based Drug For Use In Treatment Of Rheumatoid Arthritis
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Why eHealth Shares Are Trading Higher By Over 18%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Australian Psychedelics: Phase 2 Trial On Psilocybin For Anxiety Will Soon Share Results
Via Benzinga
Psyched: Psychedelic Therapy In The Workplace, UCL's Brain Imaging Study, COMPASS Trials And More
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Via InvestorPlace
Incannex Files A Provisional Patent Application Of Its THC-Based IHL-42X For The Treatment Of Obstructive Sleep Apnea
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.